Short term adherence tool predicts failure on second line protease inhibitor-based antiretroviral therapy: an observational cohort study

[1] Ajose O(2012)Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis AIDS 26 929-938

[2] Mookerjee S(2012)Second-line antiretroviral treatment successfully resuppresses drug-resistant HIV-1 after first-line failure: prospective cohort in Sub-Saharan Africa J Infect Dis 205 1739-1744

[3] Mills EJ(2013)Outcomes of second combination antiretroviral therapy regimens among HIV-infected persons in clinical care: a multicentre cohort study AIDS Res. Hum. Retroviruses 29 574-580

[4] Boulle A(2012)Second-line antiretroviral therapy in a workplace and community-based treatment programme in South Africa: determinants of virological outcome PLoS One 7 e36997-63

[5] Ford N(2011)Virologic and immunologic outcomes of the second-line regimens of antiretroviral therapy among HIV-infected patients in Thailand J Int Assoc Physicians AIDS Care (Chic) 10 57-506

[6] Sigaloff KCE(2010)High rates of survival, immune reconstitution, and virologic suppression on second-line antiretroviral therapy in South Africa J Acquir Immune Defic Syndr 53 500-312

[7] Hamers RL(2010)Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries JAMA 304 303-163

[8] Wallis CL(2012)Second-line antiretroviral therapy: long-term outcomes in South Africa J Acquir Immune Defic Syndr 61 158-1687

[9] Kityo C(2011)Protease inhibitor resistance is uncommon in HIV-1 subtype C infected patients on failing second-Line lopinavir/r-containing antiretroviral therapy in South Africa AIDS Res Treat 2011 769627-339

[10] Siwale M(2010)Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa AIDS 24 1679-84

[1] Ajose O(2012)Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis AIDS 26 929-938

[2] Mookerjee S(2012)Second-line antiretroviral treatment successfully resuppresses drug-resistant HIV-1 after first-line failure: prospective cohort in Sub-Saharan Africa J Infect Dis 205 1739-1744

[3] Mills EJ(2013)Outcomes of second combination antiretroviral therapy regimens among HIV-infected persons in clinical care: a multicentre cohort study AIDS Res. Hum. Retroviruses 29 574-580

[4] Boulle A(2012)Second-line antiretroviral therapy in a workplace and community-based treatment programme in South Africa: determinants of virological outcome PLoS One 7 e36997-63

[5] Ford N(2011)Virologic and immunologic outcomes of the second-line regimens of antiretroviral therapy among HIV-infected patients in Thailand J Int Assoc Physicians AIDS Care (Chic) 10 57-506

[6] Sigaloff KCE(2010)High rates of survival, immune reconstitution, and virologic suppression on second-line antiretroviral therapy in South Africa J Acquir Immune Defic Syndr 53 500-312

[7] Hamers RL(2010)Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries JAMA 304 303-163

[8] Wallis CL(2012)Second-line antiretroviral therapy: long-term outcomes in South Africa J Acquir Immune Defic Syndr 61 158-1687

[9] Kityo C(2011)Protease inhibitor resistance is uncommon in HIV-1 subtype C infected patients on failing second-Line lopinavir/r-containing antiretroviral therapy in South Africa AIDS Res Treat 2011 769627-339

[10] Siwale M(2010)Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa AIDS 24 1679-84